Sugentech, Inc. Logo

Sugentech, Inc.

Develops advanced in-vitro diagnostic systems for hospitals, clinics, and at-home use.

253840 | KO

Overview

Corporate Details

ISIN(s):
KR7253840003
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노2로 206 사무동2층 수젠텍, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sugentech, Inc. is an in-vitro diagnostic (IVD) company that develops and commercializes next-generation diagnostic products by integrating biotechnology (BT), nanotechnology (NT), and information technology (IT). The company specializes in immunochemical diagnostics, leveraging its proprietary platforms for high-level antibody development and high-sensitivity immunoassay technologies. Sugentech offers a range of diagnostic systems tailored to various healthcare settings: multi-immunoblot automation systems for hospitals and medical centers, point-of-care testing (POCT) for smaller clinics, and mobile health (m-Health) solutions for personal, at-home use. Its products are designed for the diagnosis of conditions such as infectious diseases, cardiovascular diseases, and diabetes, aiming to provide personalized and accessible digital healthcare solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-08 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 35.7 KB
2025-09-08 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 6.2 KB
2025-08-29 00:00
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
Korean 53.4 KB
2025-08-29 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 42.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 30.2 KB
2025-03-26 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.3 KB
2025-03-18 00:00
Annual / Quarterly Financial Statement
[첨부추가]사업보고서 (2024.12)
Korean 663.6 KB
2025-03-11 00:00
Audit Report / Information
감사보고서제출
Korean 25.0 KB
2025-03-10 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 176.4 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 17.7 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 167.5 KB
2025-03-07 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 170.6 KB

Automate Your Workflow. Get a real-time feed of all Sugentech, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sugentech, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sugentech, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

PureTech Health plc Logo
A clinical-stage biotherapeutics firm developing new medicines for devastating diseases.
United States of America
PRTC
PURPLE BIOTECH LTD. Logo
Develops first-in-class therapies targeting tumor immune evasion and drug resistance in cancer.
United States of America
PPBT
Pyxis Oncology, Inc. Logo
Developing next-gen ADC and Immuno-Oncology therapeutics for difficult-to-treat cancers.
United States of America
PYXS
PZ Cormay S.A. Logo
Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.
Poland
CRM
Q32 Bio Inc. Logo
Clinical-stage biotech developing biologic therapies for autoimmune and inflammatory diseases.
United States of America
QTTB
Quantum Biopharma Ltd. Logo
Develops therapies for brain disorders and a functional beverage for post-alcohol wellness.
United States of America
QNTM
Quantum Genomics Logo
Biopharma developing cardiovascular treatments, now in judicial liquidation.
France
ALQGC
QuidelOrtho Corp Logo
Manufactures in-vitro diagnostic tests for at-home, point-of-care, and clinical lab settings.
United States of America
QDEL
Quince Therapeutics, Inc. Logo
Late-stage biotech developing red blood cell-encapsulated drugs for rare diseases.
United States of America
QNCX
Quoin Pharmaceuticals, Ltd. Logo
Clinical-stage pharma developing therapies for rare and orphan diseases like Netherton Syndrome.
United States of America
QNRX

Talk to a Data Expert

Have a question? We'll get back to you promptly.